Vidofludimus (hemicalcium) [CAS 1354012-90-0]
Vidofludimus (hemicalcium) [CAS 1354012-90-0]
SKU:QM-0068162
Request quote or documents
![Vidofludimus (hemicalcium) [CAS 1354012-90-0]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
Vidofludimus (4sc-101; SC12267) hemicalcium is an orally active inhibitor for dihydroorotate dehydrogenase (DHODH) and also is a novel modulator for farnesoid X receptor (FXR) . Vidofludimus hemicalcium, as an immunomodulatory agent, can be used for the research of autoimmune disorders such as inflammatory bowel disease (IBD) . Vidofludimus hemicalcium also can be used for the research of fatty liver by targeting FXR[1][2][3].
-
CAS Number
[1354012-90-0]
-
Molecular Formula
C20H18FNO4.1/2Ca
-
Molecular Weight
375.4
-
Smiles
O=C(C1=C(C(NC2=CC=C(C3=CC=CC(OC)=C3)C=C2F)=O)CCC1)O.[Ca].[1/2]
-
Target
Dihydroorotate Dehydrogenase; FXR; Interleukin Related
-
Solubility
10 mM in DMSO
-
Shipping Conditions
Room temperature
-
Hazard Statement
H302-H360-H413
-
Precautions
P264-P270-P273-P280-P330-P405-P501
Related Products
Other industry favorites
Vidofludimus (hemicalcium) [CAS 1354012-90-0]
Vidofludimus (hemicalcium) is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.